In a skin cancer model for squamous cell carcinoma (SCC), transforming growth factor β (TGF-β)-responsive tumour-initiating stem cells promoted skin cancer resistance to adoptive cytotoxic T-cell transfer (ACT)-based immunotherapy [191]. The gene discussed is TGFB1; the disease is skin cancer.